These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 18722267)
1. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267 [TBL] [Abstract][Full Text] [Related]
2. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma. Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy. Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820 [TBL] [Abstract][Full Text] [Related]
4. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088 [TBL] [Abstract][Full Text] [Related]
5. FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy. Schrijvers ML; Pattje WJ; Slagter-Menkema L; Mastik MF; Gibcus JH; Langendijk JA; van der Wal JE; van der Laan BF; Schuuring E Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1220-6. PubMed ID: 22208968 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902 [TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy. Douglas CM; Bernstein JM; Ormston VE; Hall RC; Merve A; Swindell R; Valentine HR; Slevin NJ; West CM; Homer JJ Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):59-65. PubMed ID: 22841149 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia. Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels. Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy. De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma. Bernstein JM; Andrews TD; Slevin NJ; West CM; Homer JJ Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150 [TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy. Pai HH; Rochon L; Clark B; Black M; Shenouda G Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):37-42. PubMed ID: 9588915 [TBL] [Abstract][Full Text] [Related]
14. Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study. Eriksen JG; Overgaard J; Radiother Oncol; 2007 Jun; 83(3):383-8. PubMed ID: 17543403 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Beasley NJ; Wykoff CC; Watson PH; Leek R; Turley H; Gatter K; Pastorek J; Cox GJ; Ratcliffe P; Harris AL Cancer Res; 2001 Jul; 61(13):5262-7. PubMed ID: 11431368 [TBL] [Abstract][Full Text] [Related]
16. Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue. van de Nieuwenhof HP; de Hullu JA; Kaanders JH; Bulten J; Massuger LF; van Kempen LC Virchows Arch; 2010 Dec; 457(6):693-703. PubMed ID: 20890613 [TBL] [Abstract][Full Text] [Related]
17. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas. Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407 [TBL] [Abstract][Full Text] [Related]
18. Diverging prognostic impacts of hypoxic markers according to NSCLC histology. Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472 [TBL] [Abstract][Full Text] [Related]
19. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Jensen R; Lee J Neurosurgery; 2012 Jul; 71(1):146-56. PubMed ID: 22472549 [TBL] [Abstract][Full Text] [Related]
20. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy. Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]